Perforated tissue matrix
US-2024408277-A1 · Dec 12, 2024 · US
US10098722B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10098722-B2 |
| Application number | US-201414262845-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 28, 2014 |
| Priority date | Apr 26, 2005 |
| Publication date | Oct 16, 2018 |
| Grant date | Oct 16, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Absorbable composite medical devices such as surgical meshes and braided sutures, which display two or more absorption/biodegradation and breaking strength retention profiles and exhibit unique properties in different clinical settings, are made using combinations of at least two types of yarns having distinctly different physicochemical and biological properties and incorporate in the subject construct special designs to provide a range of unique properties as clinically useful implants.
Opening claim text (preview).
What is claimed is: 1. An absorbable/biodegradable surgical implant comprising: a warp-knitted composite mesh, the mesh comprising: at least first and second fibrous components, the fibrous components having differing absorption profiles and differing strength retention profiles in a biological environment; wherein the first fibrous component comprises a slow-absorbing, biodegradable multifilament yarn component having an individual filament diameter of less than about 20 microns, the slow-absorbing yarn component comprising a segmented copolymer comprising at least 80 percent of l-lactide-based sequences; wherein the second fibrous component comprises a fast-absorbing multifilament yarn component having an individual filament diameter of greater than 20 microns, the fast-absorbing yarn component comprising a segmented polyaxial copolymer comprising at least 70 percent of glycolide-based sequences; wherein the composite mesh is knit in a four bar pattern wherein the slow-absorbing yarn component is knit in a two bar pattern and the fast-absorbing yarn component is knit in a two bar pattern and are initially mechanically interdependent, and wherein upon incubation in a buffered solution at a pH of 7.2 at about 50° C. for about 2 weeks the composite mesh retains more than 20 percent of its maximum burst force and undergoes at least 12 percent elongation under a force of 16 N per cm of mesh width. 2. The implant of claim 1 wherein the slow-absorbing yarn component is knitted in a 2-bar sand-fly net pattern and the fast-absorbing yarn component is knitted in a standard 2-bar marquisette pattern, with all guide bars threaded 1-in and 1-out, using a warp knitting machine. 3. The implant of claim 2 having an area weight of about 130 g/m 2 and exhibiting a maximum burst force of at least 250 N and a maximum elongation of less than 10 percent under a 16 N force per cm of mesh width. 4. The implant of claim 2 wherein the segmented copolymer of the slow-absorbing, biodegradable multifilament yarn component is made from an 88/12 (molar) mixture of l-lactide/trimethylene carbonate and the segmented polyaxial copolymer of the fast-absorbing, biodegradable multifilament yarn component is made by copolymerization of a combination of 88/7/5 (weight) glycolide/trimethylene carbonate/l-lactide. 5. The implant of claim 4 wherein the slow-absorbing biodegradable multifilament yarn component has a denier range of 80-100 g/9000 m, a tenacity range of 1.8-4.5 g/denier, and an ultimate elongation of 20-30% and the fast-absorbing biodegradable multifilament yarn component has a denier range of 120-170 g/9000 m, a tenacity range of 3.5-5.5 g/denier, and an ultimate elongation of 40-70%. 6. The implant of claim 4 wherein the slow absorbing yarn component is on Bar 1 and Bar 2, the fast-absorbing yarn component is on Bar 3 and Bar 4, and the mesh is knit in the following pattern at 28 courses per inch: Bar 1-1-0/1-2/2-3/2-1//2 times; Bar 2-2-3/2-1/1-0/1-2//2 times; Bar 3-1-0/0-1//4 times; Bar 4-0-0/3-3//4 times. 7. The implant of claim 2 wherein the slow absorbing yarn component is on Bar 1 and Bar 2, the fast-absorbing yarn component is on Bar 3 and Bar 4, and the mesh is knit in the following pattern at 28 courses per inch: Bar 1-1-0/1-2/2-3/2-1/12 times; Bar 2-2-3/2-1/1-0/1-2/12 times; Bar 3-1-0/0-1//4 times; Bar 4-0-0/3-3//4 times. 8. The implant of claim 2 wherein the slow absorbing yarn component is on Bar 1 and Bar 2, the fast-absorbing yarn component is on Bar 3 and Bar 4, and the mesh is knit in the following pattern at 19 courses per inch: Bar 1-1-0/2-3//4 times; Bar 2-2-3/1-0//4times; Bar 3-1-0/0-1//4 times; Bar 4-0-0/3-3//4 times. 9. The implant of claim 1 wherein the slow-absorbing yarn component is knitted in a 2-bar full tricot net pattern and the fast-absorbing yarn component is knitted in a standard 2-bar marquisette net pattern with all guide bars threaded 1-in and 1-out, using a warp knitting machine. 10. The implant of claim 9 having an area weight of about 130 g/m 2 and exhibiting a maximum burst force of at least 250 N and a maximum elongation of less than 10 percent under a 16 N force per cm of mesh width. 11. The implant of claim 9 wherein the segmented copolymer of the slow-absorbing, biodegradable multifilament yarn component is made from an 88/12 (molar) mixture of l-lactide/trimethylene carbonate and the segmented polyaxial copolymer of the fast-absorbing, biodegradable multifilament yarn component is made by copolymerization of a combination of 88/7/5 (weight) glycolide/trimethylene carbonate/l-lactide. 12. The implant of claim 11 wherein the slow-absorbing biodegradable multifilament yarn component has a denier range of 80-100 g/9000 m, a tenacity range of 1.8-4.5 g/denier, and an ultimate elongation of 20-30% and the fast-absorbing biodegradable multifilament yarn component has a denier range of 120-170 g/9000 m, a tenacity range of 3.5-5.5 g/denier, and an ultimate elongation of 40-70%. 13. The implant of claim 11 wherein the slow absorbing yarn component is on Bar 1 and Bar 2, the fast-absorbing yarn component is on Bar 3 and Bar 4, and the mesh is knit in the following pattern at 19 courses per inch: Bar 1-1-0/2-3//4 times; Bar 2-2-3/1-0//4 times; Bar 3-1-0/0-1//4 times.; Bar 4-0-0/3-3//4 times. 14. The implant of claim 1 wherein the mesh is coated with an absorbable polymer coating, the coating present in an amount comprising at least 0.1 percent of the uncoated mesh weight. 15. The implant of claim 14 wherein the absorbable polymer coating comprises a polyaxial copolyester comprising molecular chains of about 95/5 γ-caprolactone-/glycolide-derived sequences. 16. The implant of claim 14 wherein the absorbable polymer coating contains at least one bioactive agent selected from antineoplastic agents, anti-inflammatory agents, antimicrobial agents, anesthetic agents and cell-growth promoting areas. 17. The implant of claim 1 wherein the segmented copolymer of the slow-absorbing, biodegradable multifilament yarn component is made from an 88/12 (molar) mixture of l-lactide/trimethylene carbonate and the segmented polyaxial copolymer of the fast-absorbing, biodegradable multifilament yarn component is made by copolymerization of a combination of 88/7/5 (weight) glycolide/trimethylene carbonate/l-lactide.
Coating · CPC title
differing in adsorbability or resorbability, i.e. in adsorption or resorption time · CPC title
Materials or treatment for tissue regeneration · CPC title
containing macromolecular fillers · CPC title
Sutures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.